In-Hospital Outcomes of Transcatheter Aortic Valve Implantation in Patients With End-Stage Renal Disease on Dialysis from a Large National Database.
The outcomes of patients with end-stage renal disease on dialysis (chronic kidney disease stage 5 on dialysis [CKD 5D]) who undergo transcatheter aortic valve implantation (TAVI) are not well described due to the exclusion of this group in randomized trials. We analyzed the National Inpatient Sample database and compared clinical characteristics and in-hospital outcomes for patients with CKD 5D versus those without CKD 5D (nondialysis group) who underwent TAVI in 2011 to 2014 in the United States. The study population included 1,708 patients (4%) with CKD 5D and 40,481 patients (96%) without CKD 5D who underwent TAVI. Patients with CKD 5D were younger (75.3 ± 9.9 vs 81.4 ± 8.4 years, p
Published In/Presented At
Bhatia, N., Agrawal, S., Yang, S., Yadav, K., Agarwal, M., Garg, L., & ... Fredi, J. L. (2017). In-Hospital Outcomes of Transcatheter Aortic Valve Implantation in Patients With End-Stage Renal Disease on Dialysis from a Large National Database. The American Journal Of Cardiology, 120(8), 1355-1358. doi:10.1016/j.amjcard.2017.07.022
Cardiology | Medical Sciences | Medicine and Health Sciences
Department of Medicine, Department of Medicine Fellows and Residents, Cardiology Division